As of 2025-06-29, the Intrinsic Value of Remedy Entertainment Oyj (REMEDY.HE) is 0.90 EUR. This REMEDY.HE valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 14.44 EUR, the upside of Remedy Entertainment Oyj is -93.80%.
The range of the Intrinsic Value is 0.22 - 1.74 EUR
Based on its market price of 14.44 EUR and our intrinsic valuation, Remedy Entertainment Oyj (REMEDY.HE) is overvalued by 93.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (32.52) - (4.01) | (6.23) | -143.1% |
| DCF (Growth 10y) | (2.74) - (11.48) | (3.46) | -124.0% |
| DCF (EBITDA 5y) | 0.22 - 1.74 | 0.90 | -93.8% |
| DCF (EBITDA 10y) | (0.06) - 2.14 | 0.86 | -94.0% |
| Fair Value | -1.92 - -1.92 | -1.92 | -113.31% |
| P/E | (5.85) - (6.50) | (6.50) | -145.0% |
| EV/EBITDA | (10.37) - 5.54 | (4.28) | -129.6% |
| EPV | (6.69) - (10.85) | (8.77) | -160.7% |
| DDM - Stable | (4.83) - (69.86) | (37.34) | -358.6% |
| DDM - Multi | 0.01 - 0.17 | 0.02 | -99.8% |
| Market Cap (mil) | 196.24 |
| Beta | 1.23 |
| Outstanding shares (mil) | 13.59 |
| Enterprise Value (mil) | 201.39 |
| Market risk premium | 5.68% |
| Cost of Equity | 7.03% |
| Cost of Debt | 11.64% |
| WACC | 7.34% |